Ever since the FDA granted BrainsWay to be the only company in the TMS industry to treat OCD, there has been an influx in physicians who have bought the machine to treat both MD and OCD patients. With the growing success regarding the OCD portion of the machine, BrainsWay is releasing a “launchpad to success.” Essentially, this is a way to consult with current and prospective clients on how to efficiently work the device.
Comments